Related Experiment Videos
Dystonia: genetics and treatment update.
1Department of Neurology, UCLA Medical Center, David Geffen UCLA School of Medicine, Los Angeles, California, USA. rbh@ucla.edu
The Neurologist
|March 15, 2006
Summary
Dystonia, a movement disorder, is better understood through genetic advances. New treatments include botulinum toxin, medications, and deep brain stimulation for optimal patient care.
Area of Science:
- Neurology
- Genetics
- Movement Disorders
Background:
- Dystonia is characterized by sustained muscle contractions causing abnormal postures and movements.
- Classification is evolving to incorporate genetic and etiologic data.
- Advances in understanding dystonia's genetics and pathophysiology are ongoing.
Purpose of the Study:
- To review the history, classification, and genetics of dystonia.
- To summarize current clinical investigation and treatment strategies.
Main Methods:
- Literature review of historical data.
- Summary of recent genetic findings.
- Overview of contemporary treatment modalities.
Main Results:
- Molecular biology advances have identified new dystonia genes and loci.
- Classification schemes have been updated based on genetic discoveries.
- Understanding of dystonia's pathophysiology has improved.
Conclusions:
- Genetic discoveries enhance dystonia classification and understanding.
- Treatment options have expanded significantly.
- A systematic approach ensures optimal long-term management for dystonia patients.